See the states with the most—and least—comprehensive ACA plans. Read post

 

The Growth Channel

The latest innovations in market strategy and share competition

Miss us at SHSMD? A recap of 'Data-Driven Primary Care Investments.'

Anna Yakovenko October 30, 2014

Consumers want it all. But providers’ budgets can’t pay for it all. So how can both traditional health care providers and new market entrants meet consumers’ growing demands in the primary care space?

This is the question we tackled during our presentation “Data-Driven Primary Care Investments” at the recent SHSMD conference in San Diego. We presented data from our Primary Care Consumer Choice Survey showing the trade-offs consumers are willing to make, and Lauren Cates, Director of Consumer Convenience and Market Development at Presbyterian Healthcare Services (PHS), then shared how she used similar data to make tough decisions about their ambulatory strategy.

Read on to see what PHS is doing.

Read more »

Another structural heart opportunity faces FDA panel scrutiny

October 23, 2014

The tumultuous road to FDA approval continues for Boston Scientific’s Watchman device—a fully percutaneous solution to left atrial appendage (LAA) closure. With no devices yet FDA-approved for percutaneous LAA closure, many structural heart programs were closely watching the FDA advisory panel’s recommendation announcement for Watchman earlier this month.

Read more »

GE wins approval for 3D mammography—DBT installs likely to increase

October 20, 2014

For the past three years, Hologic has dominated the digital breast tomosynthesis market as the only FDA-approved vendor in the United States—leaving hundreds of providers working with GE out in the cold when it comes to 3D mammography.

Last month, GE won approval for its 3D mammography technology, increasing competition for Hologic and for the breast imaging market. With 180 units installed in Europe, Australia, Latin America, Southeast Asia, and the Middle East, GE can hope to rapidly grow its tomosynthesis market share.

Read more »

Virginia Mason offers warranties on joint replacements. Here's what it means.

October 16, 2014

In September, Virginia Mason Medical Center made headlines by announcing that it would soon offer warranties on hip and knee replacements, joining the ranks of a few other early adopters providing similar surgical warranties. While warranty programs represent a novel way to enact and communicate a hospital’s commitment to high-quality care, it is not yet clear how widespread these programs may become among orthopedic providers.

Read on to see Service Line Strategy Advisor’s take on the long-term implications of warranties and the potential role of such programs within joint replacements.

Read more »

A new remote monitoring device to lower your HF readmissions

October 14, 2014

As heart failure (HF) readmission rates continue to pose severe financial burdens, hospital leaders have begun to seek alternative tools, such as remote monitoring, to manage HF populations.

One breakthrough remote monitoring device called CardioMEMS HF System has shown to drastically reduce hospital readmission rates. Below we explore the impact of the rise of remote monitoring and how CardioMEMS will play a role.

Read more »

Outpatient joint replacement finally taking off…sort of

Michael Koppenheffer October 8, 2014

The idea that patients could have a major operation like total hip or knee replacement surgery and leave the hospital the same day would have been unimaginable a generation ago. So it’s no surprise that outpatient joint replacement has captured the imagination of orthopedists, patients, and the general public for more than a decade. According to the public website for one of the pioneers of minimally invasive joint replacement, Richard Berger, MD, who practices at Rush University Medical Center:

“…instead of being in the hospital for four to five days, our patients are in the hospital for four to five hours. Instead of being able to drive in two months, they’re able to drive in a week. Instead of being able to go back to work in three months, they are off work for a week or less.”

Those are powerful claims.

Read more »

NIH says sex matters: Invest in women’s health

October 6, 2014

Research shows sex matters when it comes to medical care. In fact, the NIH recently announced that grant applicants will soon have to report the sex balance of their preclinical studies—ensuring a complete picture of appropriate treatment for both men and women.

Over the past few years an increasing amount of literature has been released indicating that a lack of attention to sex differences in the etiology of certain diseases has resulted in inadequate methodologies and strategies to prevent, diagnose, and treat diseases in women, as compared with men. The NIH’s recent announcement places a spotlight on the need for hospitals and health systems to reconsider standard services and treatment options for women.

Progressive providers have found tailoring services to women is not just good medical practice; it’s also good business practice.

Read more »

What structural heart program leaders can learn from heart failure clinics

October 3, 2014

Structural heart disease (SHD) is a popular topic among cardiovascular service line planners lately, buoyed by evidence that transcatheter valve therapies are meeting longer-term clinical goals.

The didactic sessions at the Transcatheter Cardiovascular Therapeutics (TCT) 2014 conference are also evidence that “structural heart” is rapidly expanding beyond valves to encompass interventional therapies for diseases that span the cardiovascular (CV) spectrum, including heart failure (HF) and atrial fibrillation.

Read more »

  • Manage your events
  • View your saved items
  • Manage your subscriptions
  • Update personal information
  • Invite a colleague